speb/financial-data huggingface dataset:
Financial ratios for PEW — quarterly report dated 2025-03-31
Total revenue: 23331000
Gross profit: 2240000
Operating income: 42000
Net income: 95000
Capital expenditures: 7000
Operating cash flow: 1280000
Depreciation & amortization: 51000
Net tangible assets: -39794
Owner earnings: 139000
Return on net tangible assets (%): -349.29888927979096
Capex to operating income (%): 16.666666666666664
Buffett classification: The Great
Stock price: 10.65
P/E ratio: 823.975730131579
Shares outstanding: 29400073
Book value: -39794
Market cap (USD): 313110777.45
Debt to equity: 0
Current ratio: 0
Quick ratio: 0
Effective tax rate (%): 0
COGS to revenue (%): 90.3990399039904
SG&A to revenue (%): 9.42094209420942
Free cash flow (dilution-adjusted): 1198000
Buyback yield (%): 0
Retained earnings: -39794
Capitalized R&D asset: 0
FCF margin (%): 5.134799194205135
Rule of 40 score: 5.134799194205135
Financial ratios for PEW — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -21320
Net income: -21320
Capital expenditures: 0
Operating cash flow: -1280000
Net tangible assets: -61114
Owner earnings: -21320
Buffett classification: The Gruesome
Stock price: 15.46
P/E ratio: 6168.907825461456
Shares outstanding: 29400073
Book value: -61114
Market cap (USD): 454525128.58000004
Debt to equity: 0
Current ratio: 0
Quick ratio: 0
Free cash flow (dilution-adjusted): -1198000
Buyback yield (%): 0
Retained earnings: -61114
Capitalized R&D asset: 0
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for PEW — quarterly report dated 2025-09-30
Total revenue: 22267000
Gross profit: 2380000
Operating income: -4179000
Net income: -3253000
Capital expenditures: 0
Operating cash flow: -2974000
Net tangible assets: 106984000
Owner earnings: -3253000
Return on net tangible assets (%): -3.0406415912659837
Buffett classification: The Gruesome
Stock price: 4.66
Shares outstanding: 29400073
Book value: 107549000
P/B ratio: 1.2738783269021563
Market cap (USD): 137004340.18
Debt to equity: 0.0009391068257259482
Current ratio: 9.065370356359235
Quick ratio: 8.509949307709768
COGS to revenue (%): 89.31153725243635
SG&A to revenue (%): 29.456145866079847
Free cash flow (dilution-adjusted): -3276000
Buyback yield (%): 0
Retained earnings: -4160000
Inventory turnover: 2.7090314671025744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8856707175334035
FCF margin (%): -14.712354605469976
Rule of 40 score: -14.712354605469976
Financial ratios for PEW — quarterly report dated 2025-12-31
Total revenue: 29624000
Gross profit: 4633000
Operating income: -839000
Net income: -1000
Capital expenditures: 8439000
Operating cash flow: 2557000
Depreciation & amortization: -108000
Net tangible assets: 106820000
Owner earnings: -8548000
Return on net tangible assets (%): -8.00224677026774
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 29400073
Book value: 107601000
P/B ratio: 0.8224293429429094
Market cap (USD): 88494219.72999999
Debt to equity: 0.06438601871729817
Current ratio: 7.194944557052581
Quick ratio: 6.686300226541076
COGS to revenue (%): 84.36065352416959
SG&A to revenue (%): 18.471509586821497
Free cash flow (dilution-adjusted): -6703000
Buyback yield (%): 0.09831150584234888
Retained earnings: -4689000
Inventory turnover: 2.9290904828879514
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7328278946265111
FCF margin (%): -22.62692411558196
Revenue growth (%): 33.039924552027664
Rule of 40 score: 10.413000436445703
Financial ratios for PEW — annual report dated 2025-12-31
Total revenue: 96449000
Gross profit: 11326000
Operating income: -4364000
Net income: -2507000
Capital expenditures: 8471000
Operating cash flow: -417000
Depreciation & amortization: 209000
Net tangible assets: 106820000
Owner earnings: -10769000
Return on net tangible assets (%): -10.08144542220558
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 29400073
Book value: 107601000
P/B ratio: 0.8224293429429094
Market cap (USD): 88494219.72999999
Debt to equity: 0.06438601871729817
Current ratio: 7.194944557052581
Quick ratio: 6.686300226541076
COGS to revenue (%): 88.25700629348154
SG&A to revenue (%): 16.267664776202967
Free cash flow (dilution-adjusted): -13182000
Buyback yield (%): 9.940762263162565
Retained earnings: -4689000
Inventory turnover: 9.976910454758556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8117531968415905
FCF margin (%): -13.667326773735342
Revenue growth (%): 3.572732544404115
Rule of 40 score: -10.094594229331227
Financial ratios for PSA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 304.49
Shares outstanding: 186745748
Market cap (USD): 56862212808.520004
Buyback yield (%): 0
Capitalized R&D asset: 8403000
Rule of 40 score: 0
Financial ratios for PSA — annual report dated 2022-12-31
Total revenue: 4182163000
Gross profit: 3129256000
Operating income: 2169438000
Net income: 4366274000
Capital expenditures: 459773000
Operating cash flow: 3117141000
Depreciation & amortization: 888146000
Net tangible assets: 9840885000
Owner earnings: 4794647000
Return on net tangible assets (%): 48.72170541572227
Capex to operating income (%): 21.193184594351163
Buffett classification: The Great
Stock price: 242.99
P/E ratio: 10.39269393229101
Shares outstanding: 186745748
Book value: 10166801000
P/B ratio: 4.463286859506741
Market cap (USD): 45377349306.520004
Debt to equity: 0.6758100212643092
Current ratio: 1.506281573016243
Quick ratio: 1.506281573016243
Effective tax rate (%): 0.3270328265534402
Interest coverage ratio: 15.914421320578937
COGS to revenue (%): 25.176134933047805
R&D to revenue (%): 0.41940020032696
SG&A to revenue (%): 1.7137543419517602
Free cash flow (dilution-adjusted): 2600665000
Buyback yield (%): 0
Retained earnings: -110231000
Capitalized R&D asset: 23170010
ROCI (R&D-adjusted, %): 12.768045549434348
FCF margin (%): 62.18468768433942
Rule of 40 score: 62.18468768433942
Financial ratios for PSA — annual report dated 2023-12-31
Total revenue: 4517690000
Gross profit: 3369744000
Operating income: 2319056000
Net income: 2160120000
Capital expenditures: 461137000
Operating cash flow: 3246648000
Depreciation & amortization: 970056000
Net tangible assets: 9625911000
Owner earnings: 2669039000
Return on net tangible assets (%): 27.727650920520663
Capex to operating income (%): 19.88468583768568
Buffett classification: The Great
Stock price: 276.05
P/E ratio: 23.864953676369833
Shares outstanding: 186745748
Book value: 10106946000
P/B ratio: 5.100567840710735
Market cap (USD): 51551163735.4
Debt to equity: 0.9006951259064806
Current ratio: 0.6177067177746651
Quick ratio: 0.6177067177746651
Effective tax rate (%): 0.49844744744329766
Interest coverage ratio: 11.530020086311477
COGS to revenue (%): 25.410021493285285
SG&A to revenue (%): 1.784805951714261
Free cash flow (dilution-adjusted): 2743945000
Buyback yield (%): 0
Retained earnings: -267910000
Capitalized R&D asset: 14524790
ROCI (R&D-adjusted, %): 12.01788631284475
Rosenberg metric: 13.710832383124288
FCF margin (%): 60.73778856008269
Revenue growth (%): 8.022810206106266
Rule of 40 score: 68.76059876618896
Financial ratios for PSA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 339.26
Shares outstanding: 186745748
Market cap (USD): 63355362466.479996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSA — annual report dated 2024-12-31
Total revenue: 4695616000
Gross profit: 3437615000
Operating income: 2201172000
Net income: 2084410000
Capital expenditures: 420024000
Operating cash flow: 3128255000
Depreciation & amortization: 1129766000
Net tangible assets: 9430419000
Owner earnings: 2794152000
Return on net tangible assets (%): 29.629139489984485
Capex to operating income (%): 19.081834586302207
Buffett classification: The Great
Stock price: 281.82
P/E ratio: 25.248721077599892
Shares outstanding: 186745748
Book value: 9813652000
P/B ratio: 5.36280343967363
Market cap (USD): 52628686701.36
Debt to equity: 0.9530635486157447
Current ratio: 0.7775496049285335
Quick ratio: 0.7775496049285335
Effective tax rate (%): 0.22349561696805145
Interest coverage ratio: 7.658887756131676
COGS to revenue (%): 26.79096842671973
SG&A to revenue (%): 2.271842501601494
Free cash flow (dilution-adjusted): 2663484000
Buyback yield (%): 0.3800208831637665
Retained earnings: -699083000
Receivables turnover: 470.69125902165194
Capitalized R&D asset: 5788200
ROCI (R&D-adjusted, %): 11.450401812684841
FCF margin (%): 56.722781419945754
Revenue growth (%): 3.938428710247936
Rule of 40 score: 60.66121013019369
Financial ratios for PSA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 281.82
Shares outstanding: 186745748
Market cap (USD): 52628686701.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSA — quarterly report dated 2025-03-31
Total revenue: 1183184000
Gross profit: 851337000
Operating income: 543438000
Net income: 410791000
Capital expenditures: 58009000
Operating cash flow: 705063000
Depreciation & amortization: 282715000
Net tangible assets: 9303053000
Owner earnings: 635497000
Return on net tangible assets (%): 6.831058578296824
Capex to operating income (%): 10.674446763016205
Buffett classification: The Great
Stock price: 284.49
P/E ratio: 32.332316097796685
Shares outstanding: 186745748
Book value: 9670352000
P/B ratio: 5.493832887212379
Market cap (USD): 53127297848.520004
Debt to equity: 0.9745827245998905
Current ratio: 0.5516947915225844
Quick ratio: 0.5516947915225844
Effective tax rate (%): 0.34593430159357813
Interest coverage ratio: 7.546806649168854
COGS to revenue (%): 28.046947896523278
SG&A to revenue (%): 2.1284939620549297
Free cash flow (dilution-adjusted): 636771000
Buyback yield (%): 0
Retained earnings: -867425000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.845983563158978
FCF margin (%): 53.81842553651841
Rule of 40 score: 53.81842553651841
Financial ratios for PSA — quarterly report dated 2025-06-30
Total revenue: 1201094000
Gross profit: 883089000
Operating income: 575159000
Net income: 361411000
Capital expenditures: 55338000
Operating cash flow: 872708000
Depreciation & amortization: 283216000
Net tangible assets: 9118992000
Owner earnings: 589289000
Return on net tangible assets (%): 6.462216437957177
Capex to operating income (%): 9.621339490471332
Buffett classification: The Great
Stock price: 281.73
P/E ratio: 68.1322757310134
Shares outstanding: 186745748
Book value: 9476349000
P/B ratio: 5.551914517293528
Market cap (USD): 52611879584.04
Debt to equity: 1.1017195546512693
Current ratio: 1.7678598007442083
Quick ratio: 1.7678598007442083
Effective tax rate (%): 0.8885208048243389
Interest coverage ratio: 8.03193732631373
COGS to revenue (%): 26.47627912553056
SG&A to revenue (%): 2.05762413266572
Free cash flow (dilution-adjusted): 806750000
Buyback yield (%): 0
Retained earnings: -1085142000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.887833221567426
FCF margin (%): 67.1679319020826
Revenue growth (%): 1.5137121529702904
Rule of 40 score: 68.68164405505289
Financial ratios for PSA — quarterly report dated 2025-09-30
Total revenue: 1224043000
Gross profit: 893193000
Operating income: 575422000
Net income: 514773000
Capital expenditures: 75944000
Operating cash flow: 875091000
Depreciation & amortization: 290364000
Net tangible assets: 9042555000
Owner earnings: 729193000
Return on net tangible assets (%): 8.064015093079334
Capex to operating income (%): 13.197966014507614
Buffett classification: The Great
Stock price: 280.22
P/E ratio: 40.66115775719031
Shares outstanding: 186745748
Book value: 9407107000
P/B ratio: 5.562804112312106
Market cap (USD): 52329893504.560005
Debt to equity: 1.0675781619152414
Current ratio: 0.4462144918112732
Quick ratio: 0.4462144918112732
Effective tax rate (%): 0.546943223004459
Interest coverage ratio: 7.220574210711238
COGS to revenue (%): 27.02927920015882
SG&A to revenue (%): 2.239055327304678
Free cash flow (dilution-adjusted): 789689000
Buyback yield (%): 0
Retained earnings: -1150224000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.95847866591184
FCF margin (%): 64.51480871178545
Revenue growth (%): 1.9106747681696852
Rule of 40 score: 66.42548347995513
Financial ratios for PSA — quarterly report dated 2025-12-31
Total revenue: 1215792000
Gross profit: 886519000
Operating income: 565683000
Net income: 510057000
Capital expenditures: 100087000
Operating cash flow: 733587000
Depreciation & amortization: 295545000
Net tangible assets: 8996515000
Owner earnings: 705515000
Return on net tangible assets (%): 7.842092187919433
Capex to operating income (%): 17.693124948071624
Buffett classification: The Great
Stock price: 254.52
P/E ratio: 26.449460989542757
Shares outstanding: 186745748
Book value: 9341834000
P/B ratio: 5.087922540794453
Market cap (USD): 47530527780.96
Debt to equity: 1.0976304010540114
Current ratio: 0.7508749545186812
Quick ratio: 0.7508749545186812
Effective tax rate (%): -2.9727536278697926
Interest coverage ratio: 6.967826568947466
COGS to revenue (%): 27.08300432968797
SG&A to revenue (%): 2.0802077987024097
Free cash flow (dilution-adjusted): 623959000
Buyback yield (%): 0
Retained earnings: -1219273000
Receivables turnover: 8.555408562501759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8867688675815093
FCF margin (%): 51.32119638885598
Revenue growth (%): -0.6740776263578976
Rule of 40 score: 50.64711876249808
Financial ratios for PSA — annual report dated 2025-12-31
Total revenue: 4824113000
Gross profit: 3514138000
Operating income: 2260491000
Net income: 1797032000
Capital expenditures: 289378000
Operating cash flow: 3186449000
Depreciation & amortization: 1151840000
Net tangible assets: 8996515000
Owner earnings: 2659494000
Return on net tangible assets (%): 29.561380156649548
Capex to operating income (%): 12.8015550603829
Buffett classification: The Great
Stock price: 254.52
P/E ratio: 26.449460989542757
Shares outstanding: 186745748
Book value: 9341834000
P/B ratio: 5.087922540794453
Market cap (USD): 47530527780.96
Debt to equity: 1.0976304010540114
Current ratio: 0.7508749545186812
Quick ratio: 0.7508749545186812
Effective tax rate (%): -0.40384310237322074
Interest coverage ratio: 7.423737664001051
COGS to revenue (%): 27.154732901157164
SG&A to revenue (%): 2.1103775968763583
Free cash flow (dilution-adjusted): 2857169000
Buyback yield (%): 0
Retained earnings: -1219273000
Receivables turnover: 33.94680806147437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.535639296652354
FCF margin (%): 59.22682573977849
Revenue growth (%): 2.736531266611239
Rule of 40 score: 61.96335700638973
Financial ratios for QSR — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 20000000
Buffett classification: The Gruesome
Stock price: 51.86
Shares outstanding: 346983973
Market cap (USD): 17994588839.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QSR — annual report dated 2022-12-31
Total revenue: 6505000000
Gross profit: 2598000000
Operating income: 2023000000
Net income: 1482000000
Capital expenditures: 100000000
Operating cash flow: 1490000000
Depreciation & amortization: 190000000
Net tangible assets: -14180000000
Owner earnings: 1572000000
Return on net tangible assets (%): -11.086036671368124
Capex to operating income (%): 4.9431537320810675
Buffett classification: The Great
Stock price: 57.42
P/E ratio: 13.443872961983807
Shares outstanding: 346983973
Book value: 4268000000
P/B ratio: 4.668186440876289
Market cap (USD): 19923819729.66
Debt to equity: 3.3952671040299904
Current ratio: 0.9678638941398866
Quick ratio: 0.9050094517958412
Effective tax rate (%): -8.571428571428571
Interest coverage ratio: 3.951171875
COGS to revenue (%): 60.06149116064565
SG&A to revenue (%): 8.62413528055342
Free cash flow (dilution-adjusted): 1254000000
Buyback yield (%): 1.6362324314483405
Retained earnings: 1121000000
Inventory turnover: 29.37593984962406
Receivables turnover: 10.594462540716613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.806107610276296
FCF margin (%): 19.277478862413528
Rule of 40 score: 19.277478862413528
Financial ratios for QSR — annual report dated 2023-12-31
Total revenue: 7022000000
Gross profit: 2802000000
Operating income: 2080000000
Net income: 1718000000
Capital expenditures: 120000000
Operating cash flow: 1323000000
Depreciation & amortization: 191000000
Net tangible assets: -14016000000
Owner earnings: 1789000000
Return on net tangible assets (%): -12.76398401826484
Capex to operating income (%): 5.769230769230769
Buffett classification: The Great
Stock price: 71.57
P/E ratio: 14.45497261211292
Shares outstanding: 346983973
Book value: 4730000000
P/B ratio: 5.250241637972515
Market cap (USD): 24833642947.609997
Debt to equity: 3.068710359408034
Current ratio: 1.013526119402985
Quick ratio: 0.9361007462686567
Effective tax rate (%): -18.2381280110117
Interest coverage ratio: 3.495798319327731
COGS to revenue (%): 60.09683850754771
SG&A to revenue (%): 10.025633722586157
Free cash flow (dilution-adjusted): 1009000000
Buyback yield (%): 2.013397716375399
Retained earnings: 1599000000
Inventory turnover: 25.42168674698795
Receivables turnover: 9.37516688918558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.789617357744623
FCF margin (%): 14.369125605240674
Revenue growth (%): 7.947732513451192
Rule of 40 score: 22.316858118691865
Financial ratios for QSR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67.66
Shares outstanding: 346983973
Market cap (USD): 23476935613.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QSR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.69
Shares outstanding: 346983973
Market cap (USD): 21405441294.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QSR — annual report dated 2024-12-31
Total revenue: 8406000000
Gross profit: 3024000000
Operating income: 2324000000
Net income: 1445000000
Capital expenditures: 201000000
Operating cash flow: 1503000000
Depreciation & amortization: 264000000
Net tangible assets: -13798000000
Owner earnings: 1508000000
Return on net tangible assets (%): -10.929120162342368
Capex to operating income (%): 8.648881239242685
Buffett classification: The Great
Stock price: 61.69
P/E ratio: 14.813454182955015
Shares outstanding: 346983973
Book value: 4843000000
P/B ratio: 4.419872247443733
Market cap (USD): 21405441294.37
Debt to equity: 3.2946520751600246
Current ratio: 0.9653130287648054
Quick ratio: 0.9052453468697124
Effective tax rate (%): 20.121614151464897
Interest coverage ratio: 3.9323181049069373
COGS to revenue (%): 64.02569593147751
SG&A to revenue (%): 8.220318819890554
Free cash flow (dilution-adjusted): 1130000000
Buyback yield (%): 0
Retained earnings: 1860000000
Inventory turnover: 37.901408450704224
Receivables turnover: 12.04297994269341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.436500808334829
FCF margin (%): 13.442778967404234
Revenue growth (%): 19.709484477356877
Rule of 40 score: 33.15226344476111
Financial ratios for QSR — quarterly report dated 2025-03-31
Total revenue: 2109000000
Gross profit: 704000000
Operating income: 517000000
Net income: 221000000
Capital expenditures: 64000000
Operating cash flow: 118000000
Depreciation & amortization: 71000000
Net tangible assets: -13915000000
Owner earnings: 228000000
Return on net tangible assets (%): -1.6385195831836148
Capex to operating income (%): 12.379110251450678
Buffett classification: The Great
Stock price: 63.66
P/E ratio: 24.98755624567873
Shares outstanding: 346983973
Book value: 4824000000
P/B ratio: 4.578980041703979
Market cap (USD): 22088999721.18
Debt to equity: 3.3055555555555554
Current ratio: 0.9630757518081462
Quick ratio: 0.9025504377617054
Effective tax rate (%): 26.885245901639344
Interest coverage ratio: 3.9166666666666665
COGS to revenue (%): 66.61925082977714
SG&A to revenue (%): 8.724513987671882
Free cash flow (dilution-adjusted): 6000000
Buyback yield (%): 0
Retained earnings: 1811000000
Inventory turnover: 8.836477987421384
Receivables turnover: 3.1152141802067947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.323177855666397
FCF margin (%): 0.2844950213371266
Rule of 40 score: 0.2844950213371266
Financial ratios for QSR — quarterly report dated 2025-06-30
Total revenue: 2410000000
Gross profit: 815000000
Operating income: 645000000
Net income: 263000000
Capital expenditures: 38000000
Operating cash flow: 449000000
Depreciation & amortization: 77000000
Net tangible assets: -14263000000
Owner earnings: 302000000
Return on net tangible assets (%): -2.117366612914534
Capex to operating income (%): 5.891472868217054
Buffett classification: The Great
Stock price: 63.92
P/E ratio: 45.82482552512397
Shares outstanding: 346983973
Book value: 5090000000
P/B ratio: 4.3574097355913555
Market cap (USD): 22179215554.16
Debt to equity: 3.1426326129666013
Current ratio: 1.0123456790123457
Quick ratio: 0.9517066085693536
Effective tax rate (%): 24.786324786324787
Interest coverage ratio: 4.923664122137405
COGS to revenue (%): 66.18257261410788
SG&A to revenue (%): 6.929460580912863
Free cash flow (dilution-adjusted): 378000000
Buyback yield (%): 0
Retained earnings: 1794000000
Inventory turnover: 9.550898203592814
Receivables turnover: 3.0976863753213366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8124182436557077
FCF margin (%): 15.684647302904564
Revenue growth (%): 14.27216690374585
Rule of 40 score: 29.956814206650414
Financial ratios for QSR — quarterly report dated 2025-09-30
Total revenue: 2449000000
Gross profit: 843000000
Operating income: 679000000
Net income: 436000000
Capital expenditures: 61000000
Operating cash flow: 592000000
Depreciation & amortization: 77000000
Net tangible assets: -13970000000
Owner earnings: 452000000
Return on net tangible assets (%): -3.2355046528274873
Capex to operating income (%): 8.98379970544919
Buffett classification: The Great
Stock price: 62.45
P/E ratio: 23.553422949836957
Shares outstanding: 346983973
Book value: 5165000000
P/B ratio: 4.1953822098451115
Market cap (USD): 21669149113.850002
Debt to equity: 3.0722168441432722
Current ratio: 1.0590094836670179
Quick ratio: 0.9831401475237092
Effective tax rate (%): 17.60299625468165
Interest coverage ratio: 5.143939393939394
COGS to revenue (%): 65.57778685177624
SG&A to revenue (%): 6.61494487545937
Free cash flow (dilution-adjusted): 499000000
Buyback yield (%): 0
Retained earnings: 1902000000
Inventory turnover: 7.435185185185185
Receivables turnover: 3.2181340341655718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9751993690298835
FCF margin (%): 20.375663536137196
Revenue growth (%): 1.6182572614107886
Rule of 40 score: 21.993920797547986
Financial ratios for QSR — quarterly report dated 2025-12-31
Total revenue: 2466000000
Gross profit: 831000000
Operating income: 651000000
Net income: 155000000
Capital expenditures: 102000000
Operating cash flow: 555000000
Depreciation & amortization: 76000000
Net tangible assets: -13862000000
Owner earnings: 129000000
Return on net tangible assets (%): -0.9306016447843023
Capex to operating income (%): 15.668202764976957
Buffett classification: The Great
Stock price: 67.02
P/E ratio: 21.632433367869766
Shares outstanding: 346983973
Book value: 5159000000
P/B ratio: 4.507630523446404
Market cap (USD): 23254865870.46
Debt to equity: 3.0440007753440588
Current ratio: 0.9789000345901072
Quick ratio: 0.9079903147699758
Effective tax rate (%): 44.534412955465584
Interest coverage ratio: 5.125984251968504
COGS to revenue (%): 66.30170316301704
SG&A to revenue (%): 7.218167072181671
Free cash flow (dilution-adjusted): 415000000
Buyback yield (%): 0
Retained earnings: 1795000000
Inventory turnover: 7.975609756097561
Receivables turnover: 3.1057934508816123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.864812533004753
FCF margin (%): 16.828872668288728
Revenue growth (%): 0.6941608819926501
Rule of 40 score: 17.52303355028138
Financial ratios for QSR — annual report dated 2025-12-31
Total revenue: 9434000000
Gross profit: 3193000000
Operating income: 2493000000
Net income: 1075000000
Capital expenditures: 265000000
Operating cash flow: 1714000000
Depreciation & amortization: 301000000
Net tangible assets: -13862000000
Owner earnings: 1111000000
Return on net tangible assets (%): -8.014716491126823
Capex to operating income (%): 10.629763337344565
Buffett classification: The Great
Stock price: 67.02
P/E ratio: 21.632433367869766
Shares outstanding: 346983973
Book value: 5159000000
P/B ratio: 4.507630523446404
Market cap (USD): 23254865870.46
Debt to equity: 3.0440007753440588
Current ratio: 0.9789000345901072
Quick ratio: 0.9079903147699758
Effective tax rate (%): 28.681710213776725
Interest coverage ratio: 4.775862068965517
COGS to revenue (%): 66.15433538265847
SG&A to revenue (%): 7.313970744117023
Free cash flow (dilution-adjusted): 1298000000
Buyback yield (%): 0
Retained earnings: 1795000000
Inventory turnover: 30.44390243902439
Receivables turnover: 11.8816120906801
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.97077979229009
FCF margin (%): 13.758744965020139
Revenue growth (%): 12.229359980965977
Rule of 40 score: 25.988104945986116
Financial ratios for RLC.AX — annual report dated 2021-06-30
Operating income: -442683.4586466165
Net income: -439496.992481203
Capital expenditures: 0
Net tangible assets: 147358.64661654134
Owner earnings: -439496.992481203
Return on net tangible assets (%): -298.2498839208723
Buffett classification: The Gruesome
Stock price: 0.015037593984962405
Shares outstanding: 776706676
Book value: 147358.64661654134
P/B ratio: 79.26104037512692
Market cap (USD): 11679799.639097745
Debt to equity: 0
Current ratio: 2.0412205656037465
Quick ratio: 2.0412205656037465
Free cash flow (dilution-adjusted): -419663.9097744361
Buyback yield (%): 0
Retained earnings: -16135978.195488721
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -300.4122722425467
Rule of 40 score: 0
Financial ratios for RLC.AX — annual report dated 2022-06-30
Operating income: -985602.7586206897
Net income: -956856.551724138
Capital expenditures: 0
Net tangible assets: 322751.7241379311
Owner earnings: -956856.551724138
Return on net tangible assets (%): -296.46830060471376
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
Shares outstanding: 776706676
Book value: 322751.724137931
P/B ratio: 33.193302250048085
Market cap (USD): 10713195.531034485
Debt to equity: 0
Current ratio: 2.8978497506568717
Quick ratio: 2.8978497506568717
Free cash flow (dilution-adjusted): -1030687.5862068966
Buyback yield (%): 0
Retained earnings: -15757443.448275862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -305.37490117310205
Rule of 40 score: 0
Financial ratios for RLC.AX — annual report dated 2023-06-30
Total revenue: 1101.9867549668875
Gross profit: 1101.9867549668875
Operating income: -508325.1655629139
Net income: -511629.13907284767
Capital expenditures: 0
Net tangible assets: -121721.85430463577
Owner earnings: -511629.13907284767
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 776706676
Book value: -254172.18543046355
Market cap (USD): 5143752.821192053
Debt to equity: -1.0422094841063057
Current ratio: 1.038712265085509
Quick ratio: 1.038712265085509
COGS to revenue (%): 0
SG&A to revenue (%): 22406.009615384613
Free cash flow (dilution-adjusted): -433824.5033112583
Buyback yield (%): 0
Retained earnings: -15642756.291390728
Receivables turnover: 0.4147557328015952
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4738.092592592596
FCF margin (%): -39367.48798076923
Rule of 40 score: -39367.48798076923
Financial ratios for RLC.AX — annual report dated 2024-06-30
Total revenue: 1258
Gross profit: 1258
Operating income: -438508.6666666667
Net income: -445264
Capital expenditures: 0
Net tangible assets: -319230
Owner earnings: -445264
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 776706676
Book value: -552563.3333333333
Market cap (USD): 0
Debt to equity: -0.8445487395110064
Current ratio: 3.9737767299499525
Quick ratio: 3.9737767299499525
COGS to revenue (%): 0
SG&A to revenue (%): 17909.962904080552
Free cash flow (dilution-adjusted): -435724.6666666667
Retained earnings: -16191905.333333334
Receivables turnover: 0.3243940175348118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -821.2490479817214
FCF margin (%): -34636.30100688925
Revenue growth (%): 14.157451923076916
Rule of 40 score: -34622.14355496617
Financial ratios for RMD.V — annual report dated 2022-05-31
Total revenue: 0
Gross profit: -385.03937007874015
Operating income: -151806.29921259842
Net income: -150729.92125984252
Capital expenditures: 55003.14960629921
Operating cash flow: -56730.708661417324
Depreciation & amortization: 385.03937007874015
Net tangible assets: 2100452.755905512
Owner earnings: -205348.031496063
Return on net tangible assets (%): -9.77636992399464
Buffett classification: The Gruesome
Stock price: 0.19685039370078738
Shares outstanding: 36213387
Book value: 2100452.755905512
P/B ratio: 3.3938490014338862
Market cap (USD): 7128619.4881889755
Debt to equity: 0
Current ratio: 0.39298603460519044
Quick ratio: 0.39298603460519044
Interest coverage ratio: -649.1380471380471
Free cash flow (dilution-adjusted): -111733.85826771654
Buyback yield (%): 0
Retained earnings: -14678655.118110236
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.227313196442461
Rule of 40 score: 0
Financial ratios for RMD.V — annual report dated 2023-05-31
Total revenue: 0
Gross profit: -292.6470588235294
Operating income: -118491.17647058822
Net income: -117022.0588235294
Capital expenditures: 78022.05882352941
Operating cash flow: -60104.41176470588
Depreciation & amortization: 292.6470588235294
Net tangible assets: 1844430.1470588234
Owner earnings: -194751.4705882353
Return on net tangible assets (%): -10.558896518731874
Buffett classification: The Gruesome
Stock price: 0.1102941176470588
Shares outstanding: 36213387
Book value: 1844430.1470588234
P/B ratio: 2.1655054665776334
Market cap (USD): 3994123.56617647
Debt to equity: 0.03986565275023172
Current ratio: 0.05212676980101208
Quick ratio: 0.05212676980101208
Interest coverage ratio: -378.28169014084506
Free cash flow (dilution-adjusted): -138126.47058823527
Buyback yield (%): 0
Retained earnings: -13824295.588235293
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.424270209394341
Rule of 40 score: 0
Financial ratios for RMD.V — annual report dated 2024-05-31
Total revenue: 0
Gross profit: -236.4963503649635
Operating income: -156371.53284671533
Net income: -554770.802919708
Capital expenditures: 3554.014598540146
Operating cash flow: -169754.74452554743
Depreciation & amortization: 236.4963503649635
Net tangible assets: 1579280.2919708027
Owner earnings: -558088.3211678831
Return on net tangible assets (%): -35.338142570717324
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 36213387
Book value: 1579280.291970803
P/B ratio: 0.6694981082577576
Market cap (USD): 1057325.1678832117
Debt to equity: 0.13865689536118733
Current ratio: 0.8997447394156749
Quick ratio: 0.8997447394156749
Interest coverage ratio: -18.321132301376895
Free cash flow (dilution-adjusted): -331808.7591240876
Buyback yield (%): 0
Retained earnings: -14278159.12408759
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.901442678777268
Rule of 40 score: 0
Financial ratios for RMD.V — quarterly report dated 2024-11-30
Total revenue: 0
Gross profit: -48.57142857142858
Operating income: -19095
Net income: -30422.857142857145
Capital expenditures: 0
Operating cash flow: -35511.42857142857
Depreciation & amortization: 48.57142857142858
Net tangible assets: 1473764.285714286
Owner earnings: -30374.285714285717
Return on net tangible assets (%): -2.0610002568737973
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
Shares outstanding: 36213387
Book value: 1473764.2857142857
P/B ratio: 0.5265435982687675
Market cap (USD): 776001.15
Debt to equity: 0
Current ratio: 0.4620299001603642
Quick ratio: 0.4620299001603642
Interest coverage ratio: -54.780737704918025
Free cash flow (dilution-adjusted): -35511.42857142857
Buyback yield (%): 0
Retained earnings: -14043872.857142858
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2956617408288784
Rule of 40 score: 0
Financial ratios for RMD.V — quarterly report dated 2025-02-28
Total revenue: 0
Gross profit: -44.44444444444444
Operating income: -24574.305555555555
Net income: -6700
Capital expenditures: 1041.6666666666667
Operating cash flow: -7734.027777777778
Depreciation & amortization: 44.44444444444444
Net tangible assets: 1426126.388888889
Owner earnings: -7697.222222222223
Return on net tangible assets (%): -0.539729317274552
Buffett classification: The Gruesome
Stock price: 0.01388888888888889
Shares outstanding: 36213387
Book value: 1426126.3888888888
P/B ratio: 0.35267821439388564
Market cap (USD): 502963.7083333334
Debt to equity: 0
Current ratio: 0.4863316806895374
Quick ratio: 0.4863316806895374
Interest coverage ratio: -59.3741610738255
Free cash flow (dilution-adjusted): -8775.694444444445
Buyback yield (%): 0
Retained earnings: -13660465.277777778
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7231506090215238
Rule of 40 score: 0
Financial ratios for RMD.V — quarterly report dated 2025-08-31
Total revenue: 0
Gross profit: -42.33576642335766
Operating income: -9497.080291970802
Net income: 74921.16788321167
Capital expenditures: 1094.890510948905
Operating cash flow: -1275.1824817518248
Depreciation & amortization: 42.33576642335766
Net tangible assets: 1541069.3430656933
Owner earnings: 73868.61313868614
Return on net tangible assets (%): 4.7933348016473545
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
P/E ratio: 3.528125621090781
Shares outstanding: 36213387
Book value: 1541069.3430656933
P/B ratio: 0.6860983723028611
Market cap (USD): 1057325.1678832117
Debt to equity: 0.02368248419786242
Current ratio: 0.6778121057187755
Quick ratio: 0.6778121057187755
Effective tax rate (%): 0
Interest coverage ratio: -13.063253012048193
Free cash flow (dilution-adjusted): -2370.0729927007296
Buyback yield (%): 0
Retained earnings: -14316370.0729927
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6162656037967759
Rule of 40 score: 0
Financial ratios for RMD.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -39.285714285714285
Operating income: -6545.714285714286
Net income: 66035.71428571429
Capital expenditures: 0
Operating cash flow: -30740.000000000004
Depreciation & amortization: 39.285714285714285
Net tangible assets: 1574082.142857143
Owner earnings: 66075
Return on net tangible assets (%): 4.197684364811239
Buffett classification: The Gruesome
Stock price: 0.02142857142857143
P/E ratio: 7.47347653917081
Shares outstanding: 36213387
Book value: 1574082.142857143
P/B ratio: 0.49298643880901116
Market cap (USD): 776001.15
Debt to equity: 0.022688959325502616
Current ratio: 0.9052002259170995
Quick ratio: 0.9052002259170995
Effective tax rate (%): 0
Interest coverage ratio: -4.339015151515151
Free cash flow (dilution-adjusted): -30740.000000000004
Buyback yield (%): 0
Retained earnings: -13943555
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.415843246517812
Rule of 40 score: 0
Financial ratios for SEPN — annual report dated 2024-12-31
Total revenue: 1075000
Operating income: -80823000
Net income: -71798000
Capital expenditures: 2103000
Operating cash flow: -67470000
Depreciation & amortization: 1401000
Net tangible assets: 420047000
Owner earnings: -72500000
Return on net tangible assets (%): -17.259973288703407
Buffett classification: The Gruesome
Stock price: 22.9
Shares outstanding: 45075533
Book value: 420047000
P/B ratio: 2.4574147790604384
Market cap (USD): 1032229705.6999999
Debt to equity: 0.060650355793518344
Current ratio: 27.77056580278621
Quick ratio: 27.77056580278621
COGS to revenue (%): 0
R&D to revenue (%): 6077.860465116279
SG&A to revenue (%): 1540.5581395348838
Free cash flow (dilution-adjusted): -72725000
Buyback yield (%): 9.687766148154555e-05
Retained earnings: -118374000
Receivables turnover: 0.9564056939501779
Capitalized R&D asset: 96717450
ROCI (R&D-adjusted, %): -10.474398315614017
FCF margin (%): -6765.116279069767
Revenue growth (%): 611.9205298013245
Rule of 40 score: -6153.195749268442
Financial ratios for SEPN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.9
Shares outstanding: 45075533
Market cap (USD): 1032229705.6999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SEPN — quarterly report dated 2025-03-31
Total revenue: 219000
Operating income: -25910000
Net income: -21476000
Capital expenditures: 382000
Operating cash flow: -23343000
Depreciation & amortization: 397000
Net tangible assets: 400266000
Owner earnings: -21461000
Return on net tangible assets (%): -5.361684479820919
Buffett classification: The Gruesome
Stock price: 5.79
Shares outstanding: 45075533
Book value: 400266000
P/B ratio: 0.6520347370748453
Market cap (USD): 260987336.07
Debt to equity: 0.06252342192442026
Current ratio: 32.1929874036473
Quick ratio: 32.1929874036473
COGS to revenue (%): 0
R&D to revenue (%): 8799.543378995433
SG&A to revenue (%): 3131.506849315069
Free cash flow (dilution-adjusted): -25207000
Buyback yield (%): 0
Retained earnings: -139850000
Receivables turnover: 0.16515837104072398
Capitalized R&D asset: 19271000
ROCI (R&D-adjusted, %): -2.9509947219756034
FCF margin (%): -11510.045662100456
Rule of 40 score: -11510.045662100456
Financial ratios for SEPN — quarterly report dated 2025-06-30
Total revenue: 119000
Operating income: -28978000
Net income: -24838000
Capital expenditures: 58000
Operating cash flow: -20287000
Depreciation & amortization: 405000
Net tangible assets: 377557000
Owner earnings: -24491000
Return on net tangible assets (%): -6.486702670060415
Buffett classification: The Gruesome
Stock price: 10.57
Shares outstanding: 45075533
Book value: 377557000
P/B ratio: 1.261924381775467
Market cap (USD): 476448383.81
Debt to equity: 0.06507891523663976
Current ratio: 22.08904607655186
Quick ratio: 22.08904607655186
COGS to revenue (%): 0
R&D to revenue (%): 18645.378151260506
SG&A to revenue (%): 5805.882352941177
Free cash flow (dilution-adjusted): -22151000
Buyback yield (%): 0
Retained earnings: -164688000
Receivables turnover: 0.04637568199532346
Capitalized R&D asset: 35099570
ROCI (R&D-adjusted, %): -4.735638236300925
FCF margin (%): -18614.285714285714
Revenue growth (%): -45.662100456621005
Rule of 40 score: -18659.947814742336
Financial ratios for SEPN — quarterly report dated 2025-09-30
Total revenue: 21495000
Operating income: -9886000
Net income: 8173000
Capital expenditures: 13000
Operating cash flow: 168807000
Depreciation & amortization: 401000
Net tangible assets: 388731000
Owner earnings: 8561000
Return on net tangible assets (%): 2.2022941314173554
Buffett classification: The Gruesome
Stock price: 18.81
P/E ratio: 25.935114882234185
Shares outstanding: 45075533
Book value: 388731000
P/B ratio: 2.181124674209157
Market cap (USD): 847870775.7299999
Debt to equity: 0.06202232392065464
Current ratio: 6.531189394543184
Quick ratio: 6.531189394543184
Effective tax rate (%): 0
COGS to revenue (%): 0
R&D to revenue (%): 112.88206559665039
SG&A to revenue (%): 33.110025587345895
Free cash flow (dilution-adjusted): 166262000
Buyback yield (%): 0
Retained earnings: -156515000
Receivables turnover: 1.8332622601279318
Capitalized R&D asset: 45489390
ROCI (R&D-adjusted, %): -1.3052840509064365
FCF margin (%): 773.4915096534078
Revenue growth (%): 17963.025210084033
Rule of 40 score: 18736.51671973744
Financial ratios for SEPN — annual report dated 2025-12-31
Total revenue: 528591.64
Operating income: -80797000
Net income: -48879000
Capital expenditures: 518000
Operating cash flow: 110189000
Depreciation & amortization: 1604000
Net tangible assets: 381926000
Owner earnings: -47793000
Return on net tangible assets (%): -12.513680660651541
Buffett classification: The Gruesome
Stock price: 27.88
Shares outstanding: 45075533
Book value: 381926000
P/B ratio: 3.29044333205909
Market cap (USD): 1256705860.04
Debt to equity: 0.06185753261102936
Current ratio: 4.727473513476205
Quick ratio: 4.727473513476205
COGS to revenue (%): 0
R&D to revenue (%): 18461.13192406902
SG&A to revenue (%): 5517.302543793541
Free cash flow (dilution-adjusted): 101195000
Buyback yield (%): 7.957311506195816e-05
Retained earnings: -167253000
Receivables turnover: 0.03847100727802038
Capitalized R&D asset: 153232860
ROCI (R&D-adjusted, %): -7.473786049775992
FCF margin (%): 19144.267964586048
Revenue growth (%): -50.82868465116279
Rule of 40 score: 19093.439279934886
Financial ratios for SEPN — quarterly report dated 2025-12-31
Total revenue: 277438.43
Operating income: -16023000
Net income: -10738000
Capital expenditures: 65000
Operating cash flow: -14988000
Depreciation & amortization: 401000
Net tangible assets: 381926000
Owner earnings: -10402000
Return on net tangible assets (%): -2.7235642506663593
Buffett classification: The Gruesome
Stock price: 27.88
Shares outstanding: 45075533
Book value: 381926000
P/B ratio: 3.29044333205909
Market cap (USD): 1256705860.04
Debt to equity: 0.06185753261102936
Current ratio: 4.727473513476205
Quick ratio: 4.727473513476205
COGS to revenue (%): 0
R&D to revenue (%): 11483.989438665725
SG&A to revenue (%): 2984.445954369047
Free cash flow (dilution-adjusted): -17709000
Buyback yield (%): 0
Retained earnings: -167253000
Receivables turnover: 0.020192025473071324
Capitalized R&D asset: 55439920
ROCI (R&D-adjusted, %): -1.8180286008323439
FCF margin (%): -6383.037850956697
Revenue growth (%): -98.7092885322168
Rule of 40 score: -6481.747139488914
Financial ratios for SMSPHARMA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.222866939206119
Shares outstanding: 93652030
Market cap (USD): 114523971.27653964
Buyback yield (%): 0
Retained earnings: 39220915.20506396
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMSPHARMA.NS — annual report dated 2023-03-31
Total revenue: 63306552.98416565
Gross profit: 15729488.428745434
Operating income: 2738294.762484775
Net income: -859841.6565164435
Capital expenditures: 3612350.791717418
Operating cash flow: 2734470.1583434837
Depreciation & amortization: 3912959.805115713
Net tangible assets: 55914689.403166875
Owner earnings: -559232.6431181487
Return on net tangible assets (%): -1.0001533569932968
Capex to operating income (%): 131.91972030211642
Buffett classification: The Gruesome
Stock price: 0.7059683313032887
Shares outstanding: 93652030
Book value: 56093203.41047504
P/B ratio: 1.178669844516652
Market cap (USD): 66115367.34226554
Debt to equity: 0.5516894623790403
Current ratio: 1.6109331204506627
Quick ratio: 0.7341674724955721
Effective tax rate (%): 27.387784861004654
Interest coverage ratio: 1.0708284113858935
COGS to revenue (%): 75.1534593382778
R&D to revenue (%): 1.716066361543736
SG&A to revenue (%): 1.7932962742627758
Free cash flow (dilution-adjusted): -909951.2789281365
Buyback yield (%): 0
Retained earnings: 35036394.640682094
Inventory turnover: 1.747690150398614
Receivables turnover: 3.5036071028445623
Capitalized R&D asset: 1086382.460414129
ROCI (R&D-adjusted, %): 4.48655689036374
FCF margin (%): -1.4373729669908502
Rule of 40 score: -1.4373729669908502
Financial ratios for SMSPHARMA.NS — annual report dated 2024-03-31
Total revenue: 84717172.32282048
Gross profit: 25032809.6894112
Operating income: 10222832.473917736
Net income: 5975056.961266339
Capital expenditures: 6244393.812207699
Operating cash flow: 6010876.603909342
Depreciation & amortization: 3779314.0664348244
Net tangible assets: 63996810.16908502
Owner earnings: 3509977.215493465
Return on net tangible assets (%): 5.484612758385623
Capex to operating income (%): 61.08281465180496
Buffett classification: The Good
Stock price: 2.133037428023033
P/E ratio: 33.432867083161426
Shares outstanding: 93652030
Book value: 64315733.30135507
P/B ratio: 3.1059785055133173
Market cap (USD): 199763285.20033592
Debt to equity: 0.5235043272887215
Current ratio: 1.609482018483147
Quick ratio: 0.9049754249387433
Effective tax rate (%): 25.57497867087803
Interest coverage ratio: 3.7690923480283143
COGS to revenue (%): 70.45131582765535
R&D to revenue (%): 1.5730763323714907
SG&A to revenue (%): 2.0108669111261626
Free cash flow (dilution-adjusted): -244070.03237798298
Buyback yield (%): 0
Retained earnings: 38958808.01055282
Inventory turnover: 2.129707254411467
Receivables turnover: 2.9905047216055998
Capitalized R&D asset: 2060542.0357421264
ROCI (R&D-adjusted, %): 12.457268116635193
Rosenberg metric: 8.563578297388325
FCF margin (%): -0.2880998334646224
Revenue growth (%): 33.82054199667149
Rule of 40 score: 33.532442163206866
Financial ratios for SMSPHARMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 67019338.27042523
Buffett classification: The Gruesome
Stock price: 4.184424271380793
Shares outstanding: 93652030
Book value: 67313640.70711896
P/B ratio: 5.821700078608847
Market cap (USD): 391879827.3960822
Debt to equity: 0.5063318272848292
Current ratio: 1.5501972835288764
Quick ratio: 0.7103661492791133
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMSPHARMA.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.78027742161091
Shares outstanding: 93652030
Market cap (USD): 260378624.4970276
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMSPHARMA.NS — quarterly report dated 2025-03-31
Total revenue: 29015150.806640167
Gross profit: 8937608.136544306
Operating income: 3760334.346504559
Net income: 2374888.9408463873
Capital expenditures: 0
Depreciation & amortization: 1010042.0855740004
Net tangible assets: 74528255.78676642
Owner earnings: 3384931.0264203874
Return on net tangible assets (%): 4.541808996718036
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.479752596569028
P/E ratio: 24.446813130101003
Shares outstanding: 93652030
Book value: 74777227.02829084
P/B ratio: 3.105676337511129
Market cap (USD): 232233864.5664605
Debt to equity: 0.4858257181646553
Current ratio: 1.7093763083109772
Quick ratio: 0.8315811086523172
Effective tax rate (%): 29.595195776321738
Interest coverage ratio: 6.35049653511283
COGS to revenue (%): 69.19675449524489
Buyback yield (%): 0
Retained earnings: 44434521.8611176
Inventory turnover: 0.6031811981349297
Receivables turnover: 1.221233103187662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8833039744531264
Rule of 40 score: 0
Financial ratios for SMSPHARMA.NS — annual report dated 2025-03-31
Total revenue: 91506675.23965396
Gross profit: 30944037.877016596
Operating income: 12234510.170680383
Net income: 8082183.773673135
Capital expenditures: 14417103.1096563
Operating cash flow: 9552174.421323357
Depreciation & amortization: 4014180.500350713
Net tangible assets: 74528255.78676642
Owner earnings: -2320738.8356324527
Return on net tangible assets (%): -3.1139046676100177
Capex to operating income (%): 117.83964301412273
Buffett classification: The Gruesome
Stock price: 2.479752596569028
P/E ratio: 28.73404899835833
Shares outstanding: 93652030
Book value: 74777227.02829084
P/B ratio: 3.105676337511129
Market cap (USD): 232233864.5664605
Debt to equity: 0.4858257181646553
Current ratio: 1.7093763083109772
Quick ratio: 0.8315811086523172
Effective tax rate (%): 27.008853391092458
Interest coverage ratio: 5.644494064473678
COGS to revenue (%): 66.18384637407615
R&D to revenue (%): 1.6391735732095676
SG&A to revenue (%): 2.704905958890223
Free cash flow (dilution-adjusted): -4871475.33317746
Buyback yield (%): 0
Retained earnings: 44434521.8611176
Inventory turnover: 1.8194579270408513
Receivables turnover: 3.8514699341053844
Capitalized R&D asset: 2751345.5276550953
ROCI (R&D-adjusted, %): 12.47995612669647
Rosenberg metric: 4.43564188718192
FCF margin (%): -5.3236283805735205
Revenue growth (%): 8.014317204735798
Rule of 40 score: 2.6906888241622777